---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-24-000247"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:27:09.692641+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q1 revenue $2.2B (+10% reported, +12% operational); adj EPS $1.38, +5% reported

## Summary
- Reported net income $599M ($1.31 diluted EPS) +9%; adjusted net income $634M ($1.38 adj EPS) +5% reported, +17% operational.
- US segment revenue $1.2B (+16%), driven by Simparica Trio, Apoquel, Cytopoint, Librela, Solensia.
- International segment revenue $1.0B (+3% reported, +8% operational); companion animal +14% operational.
- FY 2024 guidance raised: revenue $9.05-9.20B, reported EPS $5.34-5.44, adj EPS $5.71-5.81; operational growth 8.5-10.5%.
- Company to sell MFA portfolio and buy a manufacturing site in Australia for vaccine development.

## SEC filing metadata
- accession: 0001555280-24-000247
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000247/0001555280-24-000247-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000247/zts-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-24-000247
- JSON: https://secwatch.observer/filing/0001555280-24-000247.json
- Plain text: https://secwatch.observer/filing/0001555280-24-000247.txt

## Key facts
- Earnings Releases
  Zoetis Inc. reported first quarter of 2024 results: revenue $2.2 billion, net income $599 million, EPS $1.31 per diluted share. Guidance raised.
  - Period: first quarter of 2024
  - Revenue: $2.2 billion
  - Net income: $599 million
  - EPS: $1.31 per diluted share
  - Guidance: raised
  - Result: reported results
  source text: Exchange Act, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Zoetis Announces First Quarter 2024 Results • Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 • Delivers 12%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528024000247/0001555280-24-000247-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.